Abstract Background Extracorporeal membrane oxygenation (ECMO) represents an advanced option for supporting refractory respiratory and/or cardiac failure. Systemic anticoagulation with unfractionated heparin (UFH) is routinely used. However, patients with bleeding..
Read MoreTags Archives: nafamostat mesilate
- Home
- nafamostat mesilate
Search
Collaborations: Luc Puis – TransplantNews – Dr. Oleksandr Babliak – Mohamed Gibreel – Prof. Elio Carvalho – Mohammed Zidan – Dr. Sam Zeraatian – Pierluigi Incarnato – The echo Lady – Sedat Gündöner – Prof. Daniel Tobler – Maria Ludmila Setti – Dr. Mario Finazzo – Mastersofultrasound – Jerry W. Jones – Omayyah Dar Odeh – Pediatricecho – Salman Butt
Recent Posts
- Quality management of comprehensive blood conservation strategies during cardiopulmonary bypass in pediatric cardiac surgery
- oXiris in severe cardiogenic shock with endotoxemia: interpreting the negative findings of the CLEAN-ECMO trial
- Association Between Targeted Temperature Management and New-Onset Brain Disability in in-Hospital Cardiac Arrest Survivors: A Nationwide Cohort Study
- Excessive Anesthetic Depth Is Associated With Increased Rate of Postoperative Delirium After Cardiac Surgery: A Retrospective Analysis of Processed Electroencephalography
- Neighborhood Opportunity and Long-Term Outcomes Following Pediatric Extracorporeal Membrane Oxygenation
We use cookies to provide you with the best possible user experience. By continuing to use our site, you agree to their use. Learn more

